Hot-melt extrusion: An emerging drug delivery technology

Pharmaceutical Technology Europe

Volumn 21, Issue 1, 2009, Pages 18-23

  Andrews, Gavin P ^a   Margetson, Daniel N ^a   Jones, David S ^a   McAllister, Mark S ^b   Diak, Osama Abu ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b PFIZER

Author keywords

[No Author keywords available]

Indexed keywords

EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; IBUPROFEN; INDOMETACIN; ITRACONAZOLE; LOPINAVIR PLUS RITONAVIR; NIFEDIPINE; NIMODIPINE; POLYMER; PROPRANOLOL; VERAPAMIL;

AREA UNDER THE CURVE; CONTROLLED DRUG RELEASE; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG DOSAGE FORM COMPARISON; DRUG MANUFACTURE; DRUG SOLUBILITY; DRUG STABILITY; ENTERIC COATED TABLET; HIGH TEMPERATURE PROCEDURES; HOT MELT EXTRUSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MATRIX TABLET; PHARMACEUTICAL ENGINEERING; PLASMA CONCENTRATION-TIME CURVE; QUALITY CONTROL; REVIEW; TABLET FORMULATION;

EID: 58249121790     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. H.S. Kaufman and J.J. Falcetta Introduction to Polymer Science and Technology (John Wiley & Sons, New York, USA, 1977).
2. J. Breitenbach, European Journal of Pharmaceutics and Biopharmaceutics, 54(2), 107-117 (2002).
3. T. Whelan and D. Dunning (Eds.), The Dynisco Extrusion Processor Handbook, 1st Edition (London School of Polymer Technology, London, UK, 1996).
4. R.J. Crawford, Plastics Engineering (Butterworth-Heinemann, Oxford, UK, 1998).
5. J.L. White, Twin Screw Extrusion: Technology and Principles (Hanser/ Gardner Publications Inc., Cincinnati, OH, USA, 1991).
6. FDA Guidance for Industry - Pharmaceutical cGMPs for the 21st Century: A Risk-Based Approach, September 2004. www.fda.gov
7. J.W. McGinity et al., American Pharmaceutical Review, 4(2), 25-36 (2001).
8. I. Ghebre-Sellassie and C. Martin (Eds.), Pharmaceutical Extrusion Technology, (Marcel Dekker Inc., New York, USA, 2003).
9. W.L. Chiou and S. Reigelman, J. Pharm. Sci., 60(9), 1281-1302 (1971).
10. J.L. Ford, Pharmaceutica Acta Helvetiae, 61(3), 69-88 (1986).
11. J.E. Patterson et al., Int. J. Pharm., 336(1), 22-34 (2007).
12. F. Zhang and J.W. McGinity, Pharmaceutical Development and Technology, 4(2), 241-250 (1999).
13. N. Follonier, E. Doelker and E.T. Cole, Drug Dev. Ind. Pharm., 20(8), 1323-1339 (1994).
14. C. Aitken-Nichol, F. Zhang and J.W. McGinity, Pharmaceutical Research, 13(5), 804-808 (1996).
15. S.U. Schilling et al., J. Pharm. Pharmacol., 59(11), 1493-1500 (2007).
16. M.A. Repka and J.W. McGinity, Biomaterials 21(14), 1509-1517 (2000).
17. M. Rahman and C.S. Brazel, Progress in Polymer Science, 29(12), 1223-1248 (2004).
18. M.M. Crowley et al., Biomaterials, 23(21), 4241-4248 (2002).
19. J.P. Liu, F. Zhang and J.W. McGinity, European Journal of Pharmaceutics and Biopharmaceuticals, 52(2) 181-190 (2001).
20. C. De Brabander et al., Int. J. Pharm., 199(2), 195-203 (2000).
21. C. De Brabander, C. Vervaet and J.P. Remon, J. Contr. Release, 89(2), 235-247 (2003).
22. E. Mehuys et al., J. Contr. Release, 96(2), 261-271 (2004).
23. B. Perissutti et al., European Journal of Pharmaceutics and Biopharmaceutics 53(1), 125-132 (2002).
24. R.J. Chokshi et al., J. Pharm. Sci., 94(11), 2463-2474 (2005).
25. L. Li, O. AbuBaker and Z. Shao, Drug Dev. Ind. Pharm., 32(8), 991-1002 (2006).
26. X. Zheng et al., Drug Dev. Ind. Pharm., 33(7), 791-802 (2007).
27. G. Verrick et al., Int. J. Pharm., 251(1-2), 165-174 (2003).
28. R.J. Chokshi et al., J. Pharm. Sci., 97(6), 2286-2298 (2008).
29. C.R. Young, J.J. Koleng and J.W. McGinity, Int. J. Pharm., 242(1-2), 87-92 (2002).
30. M. Fukuda, N.A. Peppas and J.W. McGinity, J. Contr. Release, 115(2), 121-129 (2006).
31. E. Mehuys, J.P. Remon and C. Vervaet, Eur. J. Pharm. Sci., 24(2-3), 207-212 (2005).
32. G.P. Andrews et al., European Journal of Pharmaceutics and Biopharmaceutics, 69(1), 264-273 (2008)
33. D.A. Miller et al., J. Pharm Sci., 96(2), 361-376 (2007).
34. M.M. Crowley et al., Drug Development and Industrial Pharmacy, 33(9), 909-926 (2007).
35. C.E. Klein et al., J. Acquir. Immune Defic. Syndr., 44(4), 401-410 (2007).
36. K. Six et al., Eur. J. Pharm. Sci., 24(2-3), 179-186 (2005).
37. F. Tanno et al., Drug. Dev. Ind. Pharm., 30(1), 9-17 (2004).
38. W.J. Curatolo, S.M. Herbig and A.J.S. Nightingale, European Patent 1745774 (2007).
39. H. Konno and L. Taylor, J. Pharm. Sci., 95(12), 2692-2705 (2006).
40. H.M. Wolff, Pharmaceutical Science and Technology Today, 3(5), 173-181 (2000).
41. M.A. Repka and J.W. McGinity, J. Contr. Release, 70(3), 341-351 (2001).
42. P.K. Mididoddi, S. Prodduturi and M.A. Repka, Drug Dev. and Ind. Pharm., 32(9), 1059-1066 (2006).
43. M.A. Repka et al., Drug Dev. Ind. Pharm., 33(10), 1043-1057 (2007).
44. A. Lendlein and R. Langer, Science, 296(5573), 1673-1676 (2002).
45. A. Gryczke, 1st International Symposium on Hot-Melt Extrusion, (Frankfurt, Germany, 21-22 March 2007).
46. J.G. Lyons et al., Int. J. Pharm., 329(1-2), 62-71 (2007).
47. G. Verreck et al., Int. J. Pharm., 327(1-2), 45-50 (2006).
48. S. Eiamtrakarn et al., Biomaterials, 23(1), 145-152 (2002).